—
points
42.1
%
39.6
%
—
points
42.1
%
39.6
%
The Rockall Score is a widely used clinical scoring system designed to predict rebleeding risk and mortality in patients with acute upper gastrointestinal (GI) bleeding. Developed by Dr. T.A. Rockall and colleagues in 1996 from a prospective audit of over 4,000 patients across the United Kingdom, it remains one of the most thoroughly validated prognostic tools for GI hemorrhage management. Unlike the Glasgow-Blatchford Score, which focuses on predicting the need for intervention, the Rockall Score specifically addresses post-endoscopy risk stratification.
The complete Rockall Score incorporates five clinical variables: patient age, hemodynamic status (shock), comorbidities, endoscopic diagnosis, and stigmata of recent hemorrhage (SRH) found at endoscopy. These parameters are summed to produce a score ranging from 0 to 11 points. A pre-endoscopy (clinical) Rockall Score using only the first three variables can also be calculated for initial assessment before endoscopy is performed.
The scoring system is particularly valuable in the post-endoscopy setting, where the diagnosis and SRH findings significantly refine risk estimates. Patients with low complete Rockall Scores (0–2) have minimal rebleeding risk (approximately 5%) and very low mortality (under 1%), and may be candidates for early discharge. In contrast, scores of 5 or higher identify patients with substantial rebleeding rates exceeding 24% and mortality exceeding 10%, necessitating intensive monitoring, possible repeat endoscopy, and consideration of surgical or interventional radiology consultation.
This calculator helps clinicians compute the complete Rockall Score and estimate associated rebleeding and mortality risks, supporting evidence-based decisions about patient disposition, intensity of monitoring, and follow-up endoscopy planning. It is most useful when combined with the Glasgow-Blatchford Score: GBS for pre-endoscopy triage and Rockall for post-endoscopy prognostication.
The Rockall Score sums points from five components:
Age: <60 = 0; 60–79 = +1; ≥80 = +2
Shock: No shock (SBP ≥100, HR <100) = 0; Tachycardia (SBP ≥100, HR ≥100) = +1; Hypotension (SBP <100) = +2
Comorbidity: None = 0; CHF, IHD, or major morbidity = +2; Renal/liver failure or disseminated malignancy = +3
Diagnosis: Mallory-Weiss or no lesion found = 0; All other diagnoses = +1; Upper GI malignancy = +2
Stigmata of Recent Hemorrhage: None or dark spot = 0; Blood, adherent clot, visible/spurting vessel = +2
Total range: 0–11. Rebleeding and mortality estimates are derived from the original UK audit data stratified by score ranges.
A Rockall Score of 0–2 indicates low risk with approximately 5% rebleeding and under 1% mortality — these patients may be candidates for early discharge. Scores of 3–4 carry moderate risk (14% rebleeding, 5% mortality). Scores of 5–6 indicate high risk (24% rebleeding, 11% mortality), warranting ICU monitoring and possible repeat endoscopy. Scores of 7 or higher indicate very high risk (42% rebleeding, 40% mortality), requiring intensive care and multidisciplinary management.
Inputs
Results
Young patient, stable, Mallory-Weiss tear, no SRH — very low risk.
Inputs
Results
Elderly with shock, comorbidities, and active bleeding — very high risk.
The Rockall Score is a clinical scoring system that predicts rebleeding and mortality risk in patients with upper gastrointestinal bleeding, using age, hemodynamic status, comorbidities, endoscopic diagnosis, and stigmata of recent hemorrhage.
The pre-endoscopy (clinical) Rockall Score uses only age, shock status, and comorbidities (maximum 7 points). The complete Rockall Score adds endoscopic diagnosis and stigmata of recent hemorrhage (maximum 11 points) for more accurate risk stratification.
A complete Rockall Score of 0–2 indicates low rebleeding risk (approximately 5%) and very low mortality (under 1%), potentially allowing early discharge with outpatient follow-up.
Rockall is better for predicting mortality and rebleeding after endoscopy, while Glasgow-Blatchford is better for pre-endoscopy triage to identify patients who need intervention. They are complementary tools.
Stigmata of recent hemorrhage (SRH) are endoscopic findings indicating recent or active bleeding: visible vessel, active spurting or oozing, adherent clot, or blood in the upper GI tract. These carry the highest risk for rebleeding.
Yes. Patients with a complete Rockall Score of 0–2 have very low risk and may be candidates for early discharge. Most guidelines recommend considering outpatient management for these low-risk patients.
Renal failure, liver failure, and disseminated malignancy score 3 points (highest). Cardiac failure, ischemic heart disease, and other major comorbidities score 2 points.
Yes. The Rockall Score has been extensively validated in multiple countries and healthcare systems since its original UK development, confirming its generalizability for upper GI bleeding risk assessment.
The maximum complete Rockall Score is 11 points: age ≥80 (2) + hypotension (2) + renal/liver failure/malignancy (3) + GI malignancy (2) + SRH (2). Scores above 8 carry extremely high mortality.
No. The Rockall Score is a prognostic aid that supplements clinical judgment. Patient-specific factors, response to initial treatment, and evolving clinical status should always be considered alongside the score.
Roboculator Team
The Roboculator Team explains calculations, planning tools, and practical formulas in clear language for real-life situations.
How helpful was this calculator?
Be the first to rate!
